Financial Analysis and Stock Valuation: Matinas BioPharma Holdings Inc. (MTNB), AngloGold Ashanti Limited (AU)

You should consider shares of Matinas BioPharma Holdings Inc. (NYSE:MTNB) and AngloGold Ashanti Limited (NYSE:AU) if you are looking for a great stocks to invest in. Starting with the MTNB shares, which traded at $1.40 at the close of the recent session, gaining 5.26%. On Wednesday, the company’s shares shed $0.07 from its value which represented in intraday trading. The stock is now -38.33% lower in year-to-date (YTD) trading. MTNB’s intraday high was $1.40 while its lowest price touched $1.30. The stock’s 52-week high price is $2.49, which means the current price is at -43.78%. In terms of trading activity, the daily trading volume rose to 3310190 against 200-day average trading volume of 1,356,958 shares.

What are analyst forecasts for Matinas BioPharma Holdings Inc. (NYSE:MTNB)?

At a consensus rating of 5.00, MTNB is trending as a streaking Strong Buy, as it has been the case a month ago when 4 analysts called it a Strong Buy. Two months ago, 4 analysts recommended, on average, that MTNB stock is a Strong Buy. The Healthcare company’s shares’ overall bullish trend saw it close higher on Wednesday compared to its opening price of $1.32 on the day.

Forecasts for Matinas BioPharma Holdings Inc. (NYSE:MTNB) give the stock a fair value for the growth from its last price.

Matinas BioPharma Holdings Inc. (NYSE:MTNB) Upgrades and Downgrades

In terms of rating changes, Aegis Capital on January 09, 2020, Initiated Matinas BioPharma Holdings Inc. (MTNB) at Buy. They believe the stock could reach $3.50 in the near term. Analysts at H.C. Wainwright have assigned a Buy rating for the stock in their research note on June 26, 2019 with an estimated price target of $4.

AngloGold Ashanti Limited (NYSE:AU) adds -$0.02 on Wednesday

The AU stock has tanked -6.76% year-to-date and is currently trading at $20.83, which is -12.66% below its 52-week high. The company shares lost -0.10% on the day and have risen nearly 84.50% off a low hit. At current levels, AngloGold Ashanti Limited has a valuation of about $3.77B. As of 01/15/20, this stock has fallen -3.30% during the week and closed at $20.85 in the previous session. However, recent AngloGold Ashanti Limited stock performance shows that AU shares are 4.46% up over the last month, and 6.44% up for the last three months.

The ratio is expected to be up by 113.70% for the current year 2019 and 91.70% for next year. Over the next 5-year period, earnings per share will be 34.20%. But will the AU stock surprise in the current quarter results, where the $0.29 actual EPS reported on 6/29/2019 surprised by -12.10% or was lower by -$0.04 from the estimated $0.33.

Sales Growth to climb 15.60% for the year

Forecasts for this fiscal year are between $4.04B and $4.27B and the consensus estimate for sales is at $4.11B.

Who owns shares in AngloGold Ashanti Limited (AU)?

Let’s briefly focus on the share ownership of the AngloGold Ashanti Limited (NYSE:AU) stock, where we find that 38.12% of shares are held by institutions. Van Eck Associates Corporation tops the list of institutional owners as it is holding 27.02 million shares or 16.96% of shares outstanding. Blackrock Inc. and Paulson & Company, Inc. held 19.52 million and 12.78 million representing 12.25% and 8.02% respectively at the close of the last trading session. As of Sep 29, 2019, Dimensional Fund Advisors LP accounted for 11.95 million shares at over 218.31 million. This represented 7.50% of shares outstanding. Ruffer LLP held 3.25 million shares at over 59.41 million representing 2.04% of shares outstanding.